Nirsense
Richmond, US · 1 known investors
NIRSense builds ruggedized, wireless hospital-quality patient monitors that measure tissue oxygen kinetics and other physiological data, including arterial (SpO2) and tissue (StO2) oxygenation, to help clinicians diagnose and treat critical conditions such as cardiogenic shock. Its devices are designed for use in uncontrolled environments including emergency and intensive care settings and military front lines.
Founders & leadership
Investors · 1
Competitors · 2
by search overlapCompanies competing with Nirsense for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2022 | $1.5M |
| U.S. Air ForceAir Force | Phase ISTTR | 2021 | $50K |
| U.S. Air ForceAir Force | Phase I | 2020 | $50K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Nirsense do?
- NIRSense builds ruggedized, wireless hospital-quality patient monitors that measure tissue oxygen kinetics and other physiological data, including arterial (SpO2) and tissue (StO2) oxygenation, to help clinicians diagnose and treat critical conditions such as cardiogenic shock. Its devices are designed for use in uncontrolled environments including emergency and intensive care settings and military front lines.
- Who are Nirsense's investors?
- Nirsense's investors include Lighthouse Network Ventures Llc.
- Where is Nirsense headquartered?
- Nirsense is headquartered in Richmond, US.




